GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » PB Ratio

HLB Pharmaceutical Co (XKRX:047920) PB Ratio : 5.33 (As of Apr. 27, 2025)


View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-27), HLB Pharmaceutical Co's share price is ₩19520.00. HLB Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2024 was ₩3,660.55. Hence, HLB Pharmaceutical Co's PB Ratio of today is 5.33.

The historical rank and industry rank for HLB Pharmaceutical Co's PB Ratio or its related term are showing as below:

XKRX:047920' s PB Ratio Range Over the Past 10 Years
Min: 2.37   Med: 4.62   Max: 13.65
Current: 5.33

During the past 11 years, HLB Pharmaceutical Co's highest PB Ratio was 13.65. The lowest was 2.37. And the median was 4.62.

XKRX:047920's PB Ratio is ranked worse than
85.15% of 929 companies
in the Drug Manufacturers industry
Industry Median: 1.83 vs XKRX:047920: 5.33

During the past 12 months, HLB Pharmaceutical Co's average Book Value Per Share Growth Rate was 25.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 17.10% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of HLB Pharmaceutical Co was 34.80% per year. The lowest was -6.80% per year. And the median was 13.75% per year.

Back to Basics: PB Ratio


HLB Pharmaceutical Co PB Ratio Historical Data

The historical data trend for HLB Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co PB Ratio Chart

HLB Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.04 4.49 3.44 5.23 6.58

HLB Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.23 9.34 4.90 6.95 6.58

Competitive Comparison of HLB Pharmaceutical Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, HLB Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLB Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where HLB Pharmaceutical Co's PB Ratio falls into.


;
;

HLB Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

HLB Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=19520.00/3660.547
=5.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


HLB Pharmaceutical Co  (XKRX:047920) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


HLB Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines